FDA Approved: DIFFERIN — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

The FDA approved a supplemental application for DIFFERIN (adapalene) submitted by Galderma Laboratories, L.P.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• DIFFERIN (ADAPALENE)

Snippet

SUPPL AP for DIFFERIN (ADAPALENE)